For citations:
Liana P., Fertilita S., Amalia E., Larasati V., Rasyid R.S., Zulissetiana E.F., Sabloak R., Sari Z.U. Anti-SARS-CoV-2 spike receptor binding domain (S-RBD) IgG antibodies following CoronaVac administration: a longitudinal study. Anti-SARS-CoV-2 S-RBD IgG antibodies. Medical Immunology (Russia). 2023;25(1):215-222. https://doi.org/10.15789/1563-0625-ASC-2553
Email this article 